论文信息 - Rare KIT (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment - 字舞流文

Rare KIT (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment

P. Went | S. Dirnhofer | A. Lugli | B. Khanlari | Z. Nikolova | Alessandro Lugli | Stefan Dirnhofer